US Bancorp’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$429K Sell
3,773
-286
-7% -$32.5K ﹤0.01% 1588
2025
Q1
$427K Buy
4,059
+3,301
+435% +$347K ﹤0.01% 1572
2024
Q4
$81.2K Buy
758
+98
+15% +$10.5K ﹤0.01% 2496
2024
Q3
$66.1K Buy
660
+12
+2% +$1.2K ﹤0.01% 2593
2024
Q2
$54.6K Sell
648
-12
-2% -$1.01K ﹤0.01% 2617
2024
Q1
$48.2K Buy
660
+48
+8% +$3.51K ﹤0.01% 2718
2023
Q4
$43.7K Buy
612
+531
+656% +$37.9K ﹤0.01% 2737
2023
Q3
$4.85K Sell
81
-194
-71% -$11.6K ﹤0.01% 3430
2023
Q2
$19.8K Sell
275
-6
-2% -$433 ﹤0.01% 2957
2023
Q1
$20.7K Buy
281
+245
+681% +$18K ﹤0.01% 2964
2022
Q4
$2.41K Sell
36
-47
-57% -$3.14K ﹤0.01% 3708
2022
Q3
$5K Sell
83
-21
-20% -$1.27K ﹤0.01% 3574
2022
Q2
$6K Sell
104
-13
-11% -$750 ﹤0.01% 3508
2022
Q1
$8K Sell
117
-383
-77% -$26.2K ﹤0.01% 3440
2021
Q4
$48K Buy
500
+70
+16% +$6.72K ﹤0.01% 2674
2021
Q3
$38K Sell
430
-961
-69% -$84.9K ﹤0.01% 2772
2021
Q2
$114K Sell
1,391
-76
-5% -$6.23K ﹤0.01% 2235
2021
Q1
$140K Buy
1,467
+944
+180% +$90.1K ﹤0.01% 2081
2020
Q4
$32K Sell
523
-1,495
-74% -$91.5K ﹤0.01% 2690
2020
Q3
$120K Sell
2,018
-72
-3% -$4.28K ﹤0.01% 1989
2020
Q2
$146K Sell
2,090
-972
-32% -$67.9K ﹤0.01% 1906
2020
Q1
$139K Sell
3,062
-96
-3% -$4.36K ﹤0.01% 1831
2019
Q4
$206K Sell
3,158
-470
-13% -$30.7K ﹤0.01% 1801
2019
Q3
$225K Sell
3,628
-1,532
-30% -$95K ﹤0.01% 1746
2019
Q2
$367K Sell
5,160
-361
-7% -$25.7K ﹤0.01% 1555
2019
Q1
$433K Sell
5,521
-10,454
-65% -$820K ﹤0.01% 1446
2018
Q4
$1.35M Buy
15,975
+3,422
+27% +$290K ﹤0.01% 876
2018
Q3
$2.15M Sell
12,553
-5,288
-30% -$905K 0.01% 777
2018
Q2
$2.31M Buy
17,841
+1,468
+9% +$190K 0.01% 750
2018
Q1
$1.69M Sell
16,373
-1,225
-7% -$126K 0.01% 849
2017
Q4
$1.5M Buy
17,598
+3,923
+29% +$335K ﹤0.01% 910
2017
Q3
$1.16M Buy
13,675
+7,032
+106% +$598K ﹤0.01% 1004
2017
Q2
$503K Buy
6,643
+479
+8% +$36.3K ﹤0.01% 1405
2017
Q1
$407K Buy
6,164
+108
+2% +$7.13K ﹤0.01% 1474
2016
Q4
$384K Buy
6,056
+1,537
+34% +$97.5K ﹤0.01% 1491
2016
Q3
$287K Buy
4,519
+2,262
+100% +$144K ﹤0.01% 1597
2016
Q2
$168K Buy
2,257
+955
+73% +$71.1K ﹤0.01% 1773
2016
Q1
$87K Buy
1,302
+18
+1% +$1.2K ﹤0.01% 2088
2015
Q4
$87K Buy
1,284
+242
+23% +$16.4K ﹤0.01% 2147
2015
Q3
$55K Buy
1,042
+111
+12% +$5.86K ﹤0.01% 2405
2015
Q2
$59K Buy
931
+110
+13% +$6.97K ﹤0.01% 2451
2015
Q1
$40K Sell
821
-189
-19% -$9.21K ﹤0.01% 2651
2014
Q4
$34K Sell
1,010
-1,473
-59% -$49.6K ﹤0.01% 2704
2014
Q3
$73K Sell
2,483
-5,162
-68% -$152K ﹤0.01% 2275
2014
Q2
$297K Sell
7,645
-659
-8% -$25.6K ﹤0.01% 1618
2014
Q1
$348K Buy
8,304
+1,988
+31% +$83.3K ﹤0.01% 1500
2013
Q4
$206K Buy
6,316
+4,631
+275% +$151K ﹤0.01% 1708
2013
Q3
$45K Buy
+1,685
New +$45K ﹤0.01% 2376